PUBLICATIONS AND PUBLIC STATEMENTS

August 2017

PUBLICATIONS

Paper on the Impact of Personalised Medicine and Genomics on the Insurance Industry

The IAA recently published a paper on the impact of personalised medicine and genomics on the insurance industry, which was developed by the Health Committee.

Personalised medicine, which tailors medical treatment to the individual characteristics of each patient, is attracting serious attention at many levels internationally. The paper discusses personalised medicine, the future of genomics, current challenges, the impact of genomics on the insurance industry and recommendations for actuaries.

PUBLIC STATEMENTS

One public statement has been issued—the Response to IAIS Consultation on Revised Insurance Core Principles (ICPs) and ComFrame material integrated with ICPs—and the relevant links are below:

• Comments for ICPs 3 and 25;
• Comments for ICPs 5, 7, and 8;
  
• Comments for ICPs 9 and 10; and
  
• Comments for ICP 12.

Table of Contents